Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.2500
-0.0100 (-3.85%)
Sep 10, 2026, 4:10 PM AEST
Dimerix Revenue
In the fiscal year ending June 30, 2026, Dimerix had annual revenue of 6.35M AUD with 13.73% growth. Dimerix had revenue of 4.24M in the half year ending June 30, 2026, a decrease of -48.70%.
Revenue
6.35M
Revenue Growth
+13.73%
P/S Ratio
23.62
Revenue / Employee
423.59K
Employees
15
Market Cap
150.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 6.35M | 767.08K | 13.73% |
| Jun 30, 2025 | 5.59M | -2.81M | -33.43% |
| Jun 30, 2024 | 8.39M | 8.36M | 22,712.87% |
| Jun 30, 2023 | 36.79K | -6.43M | -99.43% |
| Jun 30, 2022 | 6.46M | 2.02M | 45.58% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BLS Pharmaceuticals | 73.91M |
| Actinogen Medical | 12.67M |
| Orthocell | 11.41M |
| Recce Pharmaceuticals | 9.47M |
| Alterity Therapeutics | 3.61M |
| Arovella Therapeutics | 3.50M |
| Nyrada | 2.01M |
| Avecho Biotechnology | 737.30K |
Dimerix News
- 6 days ago - DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES - PRNewsWire
- 14 days ago - Dimerix Annual report: H2 2026 - Filings
- 4 weeks ago - Dimerix Slides: Investor presentation - Filings
- 6 weeks ago - Dimerix Slides: Investor presentation - Filings
- 2 months ago - DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES - PRNewsWire
- 2 months ago - Dimerix Slides: Investor presentation - Filings
- 6 months ago - Dimerix Quarterly report: H1 2026 - Filings
- 7 months ago - Dimerix Earnings release: Q2 2026 - Filings